Accepted at 7:23 p.m. Apr, 01, 2025 by mitchelnelson
Author: jphillips767
Related Note: 1488767955829 1
Rationale for change

this card should have "likely" because it is not 100% of the time! This is why there the 4T Score is widely used in hospitals!

source: https://www.mdcalc.com/calc/1787/4ts-score-heparin-induced-thrombocytopenia

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_dorian #AK_Step2_v12::Original_decks::Dorian::im::emma #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::03_Hypercoagulable_Disorders_DDx #AK_Step2_v12::#Resources_by_rotation::Surgery::devirgilio_dorian::surgical_cxs #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Hematology_and_Oncology::Heparin_Induced_Thrombocytopenia #AK_Step2_v12::Original_decks::Dorian::im::uw::heme/onc #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::thrombocytopenia #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #PANCE::HEME::coagulation_disorders #AK_Step2_v12::#AMBOSS::Bx0zAR #AK_Step1_v12::#AMBOSS::z4arNk #AK_Step2_v12::#UWorld::COMLEX::101104 #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step2_v12::#FirstAid::07_Hematology::02_Hypercoagulable_States::03_Heparin-Induced_Thrombocytopenia_(HIT) #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_zanki #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Other::!AK_UpdateTags::AnKing_Image::AhmedA::Heparin_Induced_Thrombocytopenia #AK_Step2_v12::#SketchyIM::01_Cardiology::05_Blood_Vessel_Disease::01_DVT_SOAP #AK_Step2_v12::Original_decks::Dorian::surg::devirgilio::surgical_cxs #AK_Step3_v12::#UWorld::5292 #AK_Step2_v12::#CMS::Surgery::Form_06 #AK_Step1_v12::#USMLERx::3462.12 #AK_Step2_v12::#UWorld::Step::2250 #AK_Step1_v12::#AMBOSS::OB0Iai #AK_Step2_v12::#AMBOSS::7T04H2 #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::HemeOnc #AK_Step2_v12::#Resources_by_rotation::Surgery::emma #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::07_Drug_reactions-hematologic #AK_Step2_v12::!Shelf::Surgery::no_dupes #AK_Step2_v12::#UWorld::Step::4316 #AK_Step2_v12::#Resources_by_rotation::IM::emma #AK_Step1_v12::#UWorld::Step::15120 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::thrombocytopenia #AK_Step1_v12::#UWorld::COMLEX::26114 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::01_Heparin::*Unfractionated_Heparin #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::01_Heparin,_LMWH,_fondaparinux,_direct_thrombin_inhibitors,_Xa_inhibitors #AK_Step2_v12::#UWorld::COMLEX::103950 #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::01_Heparin_LMWH_Fondaparinux #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::02_Heparin #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::09_Thrombocytopenia #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#SketchyPath::09_Blood_&_Coagulation::03_Coagulopathies_&_Platelet_Disorders::01_Quantitative_Platelet_Disorders #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Thrombocytopenia #AK_Step1_v12::#UWorld::Step::14791 #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::#AMBOSS #AK_Step1_v12::#UWorld::COMLEX::25933 #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step2_v12::#UWorld::Step::18551 #AK_Step2_v12::#AMBOSS::uT0ps2 #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step2_v12::Original_decks::Dorian::surg::emma